CIPDB › China Industry › Chemicals › Pharmaceutical Intermediate
Pharmaceutical Intermediates Medical Raw Material Liraglutide CAS 204656-20-21
Pharmaceutical IntermediateLiraglutideCAS 204656-20-2
Farmasino Co., Ltd.
Preview:
Product Description Product DescriptionLiraglutide is a synthetic cellulosic human insulin-like peptide-1 (GLP-1) analog with greater than 97% sequence similarity to native human GLP-1. It is precisely because of this unique molecular change that it helps to improve the clinical treatment effect, and only requires one subcutaneous injection per day, gaining outstanding clinical advantages in the treatment of diabetes, weight loss, etc. Product ParametersProduct NameLiraglutide Powder 99% Appearancewhite powderAssay99%min, 98.0% --101.0%TestHPLC CertificateISO 9001 CAS204656-20-2MFC172H265N43O51Storage TemperatureCool Dry PlaceCompany Profile
Purchasing Agent
Note: Send your message to supplier or manufacturer.
Welcome to our Professional and comprehensive procurement services...